Clinical trials
Transplantation clinical trials
Below are recruiting transplantation clinical trials, each written for real people, not researchers. We’re tracking 1,499 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06254248RecruitingPhase 2
Safety of two cancer drugs after liver transplant
This trial tests a combination of two drugs (atezolizumab and bevacizumab) for people whose liver cancer has returned after a liver transplant and cannot be treated with surgery or other local procedures. The goal is to see if this treatment is safe for liver transplant recipients.
ClichyAges 18–90 - NCT06706154Recruiting
Exercise capacity in kidney transplant recipients
This study looks at how well your body can handle exercise after a kidney transplant. It aims to understand your current fitness level, which can help guide your recovery and long-term health.
AnkaraAges 18–65 - NCT07033858Recruiting
Short-term effects of Advograf plus Rapamiune after kidney transplant
This trial tests a combination of two medications (Advograf and Rapamiune) given shortly after kidney transplant to see how well they work and how safe they are. It may help improve long-term transplant health.
TehranAges 18 years+ - NCT06706492Recruiting
Muscle oxygen and frailty in kidney transplant patients
This study looks at how well muscles use oxygen and how frailty affects kidney transplant recipients, especially those with weak breathing muscles. It may help understand why some patients feel more tired or weak after transplant.
AnkaraAges 18–65 - NCT06032195RecruitingPhase 2
Study of heart preservation in children needing a first transplant
This study looks at how the heart muscle is kept healthy after donation and before transplant in children. It aims to improve transplant success.
BerlinAges 1 day–17 years - NCT04026893Recruiting
Uterus transplant study for people with uterine infertility
This trial looks at whether transplanting a deceased donor uterus can allow pregnancy for people who cannot conceive because their uterus does not work or is absent. You would also need to take anti-rejection medicines and come to frequent follow-up visits after surgery.
Boston, MassachusettsAges 18–40 - NCT05973734Enrolling by invitationPhase 1
Islet transplant with immune cells to treat type 1 diabetes
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
Palo Alto, CaliforniaAges 18–70 - NCT05968833Recruiting
Parent peer support for kids after kidney transplant
This program pairs parents with other parents who have been through a pediatric kidney transplant. It may help you cope and adjust by sharing experiences and support through WhatsApp.
Toronto, OntarioAges 18–75 - NCT05968807Recruiting
WhatsApp support for parents after a child’s organ transplant
This program pairs parents together using WhatsApp—experienced parents (mentors) and newer parents (mentees). It aims to help parents cope and adjust after a child’s solid organ transplant.
Toronto, OntarioAges 18–75 - NCT06493526RecruitingPhase 4
Mycophenolate therapy for kidney transplant patients with no DQ mismatch
This trial tests a mycophenolate-based therapy for kidney transplant recipients who have no HLA-DQ mismatch. If you had your first kidney transplant 3-12 months ago without DQ mismatch and are on standard immunosuppressants, you may qualify.
Edegem, AntwerpAges 18 years+ - NCT06478017RecruitingPhase 2
Belatacept for heart transplant patients
This study tests whether a drug called belatacept can safely help your body accept a new heart without rejecting it, and may reduce the need for other strong immune-suppressing medicines. If you are getting a heart transplant for the first time and have certain immune markers, this trial may be an option for you.
Los Angeles, CaliforniaAges 18–71 - NCT07047183RecruitingPhase 2
A study of venetoclax and azacitidine before stem cell transplant for MDS
This trial tests a combination of two drugs (venetoclax and azacitidine) given before a stem cell transplant to see if it improves outcomes for people with a certain type of myelodysplastic syndromes (MDS) that is higher risk. If you have higher-risk MDS and are planning a stem cell transplant, this may be an option.
Changchun, JilinAges 18 years+ - NCT06262451Enrolling by invitation
Fecal transplant national registry study
This study creates a registry for people who receive fecal microbiota transplants (FMT) to track long-term safety and outcomes. It may help researchers understand how this treatment works over time.
San Francisco, CaliforniaAges Any age - NCT06314230Recruiting
Genomics of chronic kidney transplant failure study
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
Westmead, New South WalesAges 18–75 - NCT06093867Recruiting
Tracking lung health after stem cell transplant
This study follows people getting a stem cell transplant to watch for lung problems, like infections or other lung diseases, that can happen after the transplant. The goal is to catch these issues early.
Bethesda, MarylandAges 5–70 - NCT07530913Enrolling by invitation
Digital Rehabilitation Platform for Liver Transplant Patients
This study tests a smartphone or tablet-based exercise program designed to help people recovering from living donor liver transplant surgery. The goal is to see if using guided exercises on a digital device at home improves recovery and quality of life after transplant.
SeoulAges 20–65 - NCT06712108Recruiting
Double cord blood transplant for blood cancers
This trial tests using a double (two units) umbilical cord blood transplant as a first-time donor stem cell transplant for adults with certain blood cancers or bone marrow failure diseases. It aims to see if this approach is effective and safe for patients who need a stem cell transplant but lack a fully matched donor.
Jeonju, Jeonlabuk-doAges 19 years+ - NCT07061444Recruiting
Breathing muscle training for stem cell transplant patients
This trial tests different breathing exercises to help people recover after a stem cell transplant. It looks at whether these exercises can improve strength and recovery.
Istanbul, ZeytinburnuAges 18–65 - NCT07102550RecruitingPhase 2
Amniotic tissue for bile duct repair in living donor liver transplant
This trial tests whether using amniotic tissue during bile duct connection surgery can improve outcomes for people receiving a liver transplant from a living donor.
Cleveland, OhioAges 18 years+ - NCT06377540RecruitingPhase 2
Pembrolizumab plus BEAM with stem cell transplant for Hodgkin lymphoma
This trial tests whether adding the immunotherapy drug pembrolizumab (Keytruda) to the standard BEAM chemotherapy before a stem cell transplant can help people with relapsed Hodgkin lymphoma. It's for patients who are eligible for a transplant and have stable organ function.
Minneapolis, MinnesotaAges 18 years+ - NCT06734013Recruiting
Genetic testing to help diagnose liver transplant rejection
This study looks at whether genetic testing of a tissue sample (biopsy) can help doctors more accurately diagnose rejection after a liver transplant. It is for people who have already been diagnosed with rejection and have a stored tissue sample available.
BolognaAges 18 years+ - NCT07574398Recruiting
Growth and Development Study After Infant Liver Transplant
This study tracks how babies grow and develop after receiving a liver transplant. Researchers want to understand how transplantation affects children's physical growth and overall development in early infancy.
Shanghai, Shanghai MunicipalityAges Up to 1 year - NCT06533852RecruitingPhase 3
Fecal transplant trial for liver cirrhosis complications
This study tests whether stool from healthy donors can help people with advanced liver disease (cirrhosis) who have had complications like fluid buildup. You would receive the transplant through a colonoscopy or enema.
BarcelonaAges 18 years+ - NCT06406179Recruiting
Blood test for donor DNA in kidney transplant care
This trial is testing whether a simple blood test that looks for donor DNA can help doctors take better care of kidney transplant patients. It may help detect early signs of rejection and guide treatment decisions.
ParisAges 18 years+
Hear when a new Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transplantation?
- Yes. Clin2 currently lists 1,499 recruiting transplantation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transplantation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transplantation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.